These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 8296653

  • 1. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
    Dringenberg C, Apenberg S, Andrassy K.
    Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
    [Abstract] [Full Text] [Related]

  • 2. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 3. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P.
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [Abstract] [Full Text] [Related]

  • 4. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M.
    Arthritis Res Ther; 2005 Mar; 7(5):R1072-81. PubMed ID: 16207324
    [Abstract] [Full Text] [Related]

  • 5. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.
    Gaudin PB, Askin FB, Falk RJ, Jennette JC.
    Am J Clin Pathol; 1995 Jul; 104(1):7-16. PubMed ID: 7611186
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J, Mirapeix E, Rodríguez R, Pascual J, Alvarez L, Darnell A.
    Med Clin (Barc); 1998 Oct 31; 111(14):536-8. PubMed ID: 9859079
    [Abstract] [Full Text] [Related]

  • 7. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
    Suzuki Y, Takeda Y, Sato D, Kanaguchi Y, Tanaka Y, Kobayashi S, Suzuki K, Hashimoto H, Ozaki S, Horikoshi S, Tomino Y.
    Mod Rheumatol; 2010 Feb 31; 20(1):54-62. PubMed ID: 19821007
    [Abstract] [Full Text] [Related]

  • 8. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X, Mirapeix E, Font J, López-Soto A, Rodríguez R, Vivancos J, Revert L, Ingelmo M, Urbano-Márquez A.
    Med Clin (Barc); 1994 Mar 26; 102(11):412-7. PubMed ID: 8182997
    [Abstract] [Full Text] [Related]

  • 9. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
    Schultz DR, Diego JM.
    Semin Arthritis Rheum; 2000 Apr 26; 29(5):267-85. PubMed ID: 10805352
    [Abstract] [Full Text] [Related]

  • 10. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.
    Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS).
    Kidney Int; 2002 Jan 26; 61(1):80-9. PubMed ID: 11786087
    [Abstract] [Full Text] [Related]

  • 11. Identification of apparent dual ANCA specificities in a subset of patients with systemic vasculitis and crescentic glomerulonephritis.
    Teeraratkul P, Thorson JA, Kemp JD, Goeken JA.
    Adv Exp Med Biol; 1993 Jan 26; 336():455-9. PubMed ID: 8296656
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ.
    Kidney Int; 1998 Mar 26; 53(3):743-53. PubMed ID: 9507222
    [Abstract] [Full Text] [Related]

  • 13. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E, Ahlquist D, Ullrich S, Gross WL.
    Rheumatology (Oxford); 2002 Nov 26; 41(11):1313-7. PubMed ID: 12422006
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of ANCA in 98 patients.
    Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P.
    Adv Exp Med Biol; 1993 Nov 26; 336():273-9. PubMed ID: 7905232
    [Abstract] [Full Text] [Related]

  • 15. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
    Csernok E, Reichel P, Gross WL.
    Z Rheumatol; 2002 Aug 26; 61(4):367-77. PubMed ID: 12426842
    [Abstract] [Full Text] [Related]

  • 16. Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
    Niles JL.
    Annu Rev Med; 1996 Aug 26; 47():303-13. PubMed ID: 8712783
    [Abstract] [Full Text] [Related]

  • 17. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
    Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL.
    Hum Pathol; 1993 Feb 26; 24(2):160-8. PubMed ID: 8381764
    [Abstract] [Full Text] [Related]

  • 18. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O, Ara J, Rodríguez R, Poveda R, Serra A, Solé-Amigó J, Fort J, Mirapeix E, Darnell A.
    Nefrologia; 2001 Feb 26; 21(4):349-54. PubMed ID: 11816510
    [Abstract] [Full Text] [Related]

  • 19. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.
    Segelmark M, Baslund B, Wieslander J.
    Clin Exp Immunol; 1994 Jun 26; 96(3):458-65. PubMed ID: 7516271
    [Abstract] [Full Text] [Related]

  • 20. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
    Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW.
    Kidney Int; 2000 Jun 26; 57(6):2195-206. PubMed ID: 10844589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.